Silence Therapeutics (SLN) Assets: 2019-2025
Historic Assets for Silence Therapeutics (SLN) over the last 4 years, with Sep 2025 value amounting to $146.8 million.
- Silence Therapeutics' Assets rose 19.53% to $146.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $146.8 million, marking a year-over-year increase of 19.53%. This contributed to the annual value of $202.6 million for FY2024, which is 69.64% up from last year.
- As of Q3 2025, Silence Therapeutics' Assets stood at $146.8 million, which was down 11.16% from $165.2 million recorded in Q2 2025.
- Silence Therapeutics' 5-year Assets high stood at $202.6 million for Q4 2024, and its period low was $5.4 million during Q1 2022.
- In the last 3 years, Silence Therapeutics' Assets had a median value of $142.0 million in 2024 and averaged $118.4 million.
- Its Assets has fluctuated over the past 5 years, first dropped by 3.92% in 2021, then spiked by 825.94% in 2024.
- Silence Therapeutics' Assets (Quarterly) stood at $11.5 million in 2021, then spiked by 125.26% to $25.9 million in 2022, then soared by 361.39% to $119.4 million in 2023, then surged by 69.64% to $202.6 million in 2024, then rose by 19.53% to $146.8 million in 2025.
- Its last three reported values are $146.8 million in Q3 2025, $165.2 million for Q2 2025, and $185.3 million during Q1 2025.